Staphylococcus epidermidis
Revision as of 04:59, 22 April 2014 by Rossdonaldson1 (talk | contribs) (Rossdonaldson1 moved page Staph. epidermidis to Staphylococcus epidermidis)
Background
Antibiotic Sensitivities[1]
Organisms | ' | Staph. epidermidis |
Penicillins | Penicillin G | 0 |
Penicillin V | 0 | |
Anti-Staphylocccal Penicillins | Methicillin | + |
Nafcillin/Oxacillin | + | |
Cloxacillin/Diclox. | + | |
Amino-Penicillins | AMP/Amox | 0 |
Amox/Clav | 0 | |
AMP-Sulb | 0 | |
Anti-Pseudomonal Penicillins | Ticarcillin | +/- |
Ticar-Clav | +/- | |
Pip-Taxo | + | |
Carbapenems | Piperacillin | 0 |
Doripenem | + | |
Ertapenem | + | |
Imipenem | + | |
Meropenem | + | |
Aztreonam | 0 | |
Fluroquinolones | Ciprofloxacin | + |
Ofloxacin | + | |
Pefloxacin | + | |
Levofloxacin | + | |
Moxifloxacin | + | |
Gemifloxacin | + | |
Gatifloxacin | + | |
1st G Cephalosporin | Cefazolin | +/- |
2nd G. Cephalosporin | Cefotetan | +/- |
Cefoxitin | +/- | |
Cefuroxime | +/- | |
3rd/4th G. Cephalosporin | CefoTAXime | +/- |
Cefizoxime | +/- | |
CefTRIAXone | +/- | |
Ceftobiprole | + | |
Ceftaroline | + | |
CefTAZidime | +/- | |
Cefepime | +/- | |
Oral 1st G. Cephalosporin | Cefadroxil | +/- |
Cephalexin | +/- | |
Oral 2nd G. Cephalosporin | Cefaclor/Loracarbef | +/- |
Cefproxil | +/- | |
Cefuroxime axetil | +/- | |
Oral 3rd G. Cephalosporin | Cefixime | 0 |
Ceftibuten | 0 | |
Cefpodox/Cefdinir/Cefditoren | +/- | |
Aminoglycosides | Gentamicin | +/- |
Tobramycin | +/- | |
Amikacin | +/- | |
Chloramphenicol | 0 | |
Clindamycin | 0 | |
Macrolides | Erythromycin | +/- |
Azithromycin | 0 | |
Clarithromycin | 0 | |
Ketolide | Telithromycin | 0 |
Tetracyclines | Doxycycline | 0 |
Minocycline | 0 | |
Glycylcycline | Tigecycline | + |
Glyco/Lipoclycopeptides | Vancomycin | + |
Teicoplanin | +/- | |
Telavancin | + | |
Fusidic Acid | + | |
Trimethoprim | + | |
TMP-SMX | +/- | |
Urinary Agents | Nitrofurantoin | |
Fosfomycin | ||
Other | Rifampin | + |
Metronidazole | 0 | |
Quinupristin dalfoppristin | + | |
Linezolid | + | |
Daptomycin | + | |
Colistimethate | 0 |
Key
- S susceptible/sensitive (usually)
- I intermediate (variably susceptible/resistant)
- R resistant (or not effective clinically)
- S+ synergistic with cell wall antibiotics
- U sensitive for UTI only (non systemic infection)
- X1 no data
- X2 active in vitro, but not used clinically
- X3 active in vitro, but not clinically effective for Group A strep pharyngitis or infections due to E. faecalis
- X4 active in vitro, but not clinically effective for strep pneumonia
Table Overview
|
See Also
References
- ↑ Sanford Guide to Antimicrobial Therapy 2010